Creative Biolabs-Immuno-oncology

Anti-CSPG4 (clone 2E2E5L.2E8Ps) SynExpress E1-TG-NF-X Modified CD8+ T cells (CAT#: ITS-1224-CR883)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CSPG4 (clone 2E2E5L.2E8Ps). We employs the Lentivirus (EF1α-TurboGFP-NF-κB-XbaI) vector components and the SynExpress system of the Multiple base pair Knockout/Delayed feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CSPG4
Clone
2E2E5L.2E8Ps
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
TurboGFP
Promoter
EF1α
Effector Gene
NF-κB
Insertion Sites
XbaI
Gene Modification
Knockout
Modification Domain
Multiple base pair
Carrier Type
Lentivirus
Transformation Accuracy
0.94
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving